AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BIOXYNE LTD

0.042

+0.0025.00%

Volume:728.90K

Turnover:30.42K

Market Cap:94.08M

PE:18.26

High:0.042

Open:0.041

Low:0.041

Close:0.040

52wk High:0.060

52wk Low:0.019

Shares:2.24B

Float Shares:595.07M

Volume Ratio:0.30

T/O Rate:0.12%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.002

EPS(LYR):0.002

ROE:63.65%

ROA:24.26%

PB:7.58

PE(LYR):18.26

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies+0.52%

Capital Flow

Inflow:

Outflow:

News

BRIEF-Bioxyne Reports Qtrly Revenue A$17.2 Mln

Bioxyne Ltd - Reports a$17.2 Mln Quarterly Revenue

THOMSON REUTERS

The 11% return this week takes Bioxyne's (ASX:BXN) shareholders five-year gains to 215%

Simply Wall St.

Bioxyne Enters Costa Rica, Panama Medicinal Cannabis Markets with Manufacturing, Supply Agreement with Remidose; Shares Rise 3%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BXN.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BXN.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BXN.AU\",,,,,undefined,":{"symbol":"BXN.AU","market":"AU","secType":"STK","nameCN":"BIOXYNE LTD","latestPrice":0.042,"timestamp":1770613920000,"preClose":0.04,"halted":0,"volume":728898,"delay":0,"changeRate":0.050000000000000044,"nameEN":"BIOXYNE LTD","floatShares":595070503,"shares":2239909288,"eps":0.0023,"marketStatus":"Closed","change":0.002,"latestTime":"02-09 16:12:00 AEDT","open":0.041,"high":0.042,"low":0.041,"amount":30423,"amplitude":0.025,"askPrice":0.043,"askSize":2293750,"bidPrice":0.041,"bidSize":290691,"shortable":3,"etf":0,"ttmEps":0.0023,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770678000000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.04,"openAndCloseTimeList":[[1770591600000,1770613200000]],"volumeRatio":0.301638,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BXN.AU\",,,,,undefined,":{"symbol":"BXN.AU","floatShares":595070503,"roa":"24.26%","roe":"63.65%","lyrEps":0.0023,"volumeRatio":0.301638,"shares":2239909288,"dividePrice":0,"high":0.042,"amplitude":0.025,"preClose":0.04,"low":0.041,"week52Low":0.019,"pbRate":"7.58","psRate":"3.21","week52High":0.06,"institutionHeld":0,"latestPrice":0.042,"committee":-0.775045,"eps":0.0023,"divideRate":0,"volume":728898,"delay":0,"ttmEps":0.0023,"open":0.041,"prevYearClose":0.042,"prevWeekClose":0.04,"prevMonthClose":0.039,"prevQuarterClose":0.042,"fiveDayClose":0.039,"twentyDayClose":0.038,"sixtyDayClose":0.04},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BXN.AU\",params:#limit:5,,,undefined,":[{"date":"2025-07-28","symbol":"BXN.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1753660800000,"name":null,"time":"","dateTimestamp":1753624800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BXN.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BXN.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606757291","title":"BRIEF-Bioxyne Reports Qtrly Revenue A$17.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2606757291","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606757291?lang=en_us&edition=fundamental","pubTime":"2026-01-28 09:38","pubTimestamp":1769564324,"startTime":"0","endTime":"0","summary":"BRIEF-Bioxyne Reports Qtrly Revenue A$17.2 MlnJan 28 (Reuters) - Bioxyne Ltd BXN.AX:REPORTS A$17.2 MILLION QUARTERLY REVENUEFurther company coverage: BXN.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YS0OU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BXN.AU","BK7111"],"gpt_icon":0},{"id":"2606012758","title":"Bioxyne Ltd - Reports a$17.2 Mln Quarterly Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2606012758","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606012758?lang=en_us&edition=fundamental","pubTime":"2026-01-28 05:22","pubTimestamp":1769548945,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nFWN3YS0OU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7111","BXN.AU"],"gpt_icon":0},{"id":"2605426527","title":"The 11% return this week takes Bioxyne's (ASX:BXN) shareholders five-year gains to 215%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605426527","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605426527?lang=en_us&edition=fundamental","pubTime":"2026-01-23 06:50","pubTimestamp":1769122245,"startTime":"0","endTime":"0","summary":"When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, you can make far...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/household/asx-bxn/bioxyne-shares/news/the-11-return-this-week-takes-bioxynes-asxbxn-shareholders-f","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/household/asx-bxn/bioxyne-shares/news/the-11-return-this-week-takes-bioxynes-asxbxn-shareholders-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","BK7111","BXN.AU"],"gpt_icon":0},{"id":"2590356926","title":"Bioxyne Enters Costa Rica, Panama Medicinal Cannabis Markets with Manufacturing, Supply Agreement with Remidose; Shares Rise 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590356926","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590356926?lang=en_us&edition=fundamental","pubTime":"2025-12-11 12:56","pubTimestamp":1765428972,"startTime":"0","endTime":"0","summary":"Bioxyne  is set to enter the Costa Rica and Panama medicinal cannabis markets after entering a manufacturing and supply agreement with Remidose LATAM, a Costa Rican entity affiliated with Canadian medicinal cannabis firm, Remidose Aerosols, according to a Thursday filing with the Australian bourse.Bioxyne's wholly-owned subsidiary, Breathe Life Sciences, will manufacture pharmaceutical-grade THC pastille products under the agreement. Supply under the agreement is subject to successful Therapeutic Goods Administration export approvals and relevant in-market product registrations, which the parties will progress immediately.The agreement has an initial 12-month rolling term with automatic renewal. Based on indicative pricing and minimum volumes, the agreement represents potential annual revenue of over AU$1 million once full supply commences, per the filing.Bioxyne's shares rose 3% in recent trading on Thursday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7111","BXN.AU","BK7508"],"gpt_icon":0}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":34,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BXN.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":0.00521}]}}